Export 2757 results:
Author [ Title(Asc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
A. Krupnick, Serle, J., Van Veldhuisen, P., Lind, L., Clarke, J., Singer, G., and Lebwohl, M., “Tacrolimus ointment for the treatment of eyelid dermatitis”, Cutis, vol. 73, pp. 267-71, 2004.
E. V. Maarseveen, Rogers, C., Trofe-Clark, J., Lghoul, F., Wong, M., Zuilen, A. V., Mudrikova, T., Barin, B., Stock, P., and Frassetto, L., “Tacrolimus Exposure and its Relation with Clinical Outcomes in HIV Infected Kidney Transplant Recipients on Antiretroviral Agents: An Area-Under-The-Curve Driven Analysis”, in World Transplant Congress, San Francisco, CA, 2014.
S. M. Bartosh and Stablein, D. M., “Tacrolimus as primary immunosuppression for children receiving non-primary renal transplants: A report of the North American Pediatric Cooperative Study (NAPRTCS)”, 2000.
I. Tellez, Sabbaj, S., Peng, X., Mulligan, M. J., and AVEG], theN. I. H. A. I. D. S. V., “T cell and antibody responses in HIV-1 seronegative volunteers immunized with recombinant canarypox and gp120 prime-boost vaccines”, 1999.
S
M. S. Natrajan, Rouphael, N., Lai, L., Kazmin, D., Jensen, T. L., Weiss, D. S., Ibegbu, C., Sztein, M. B., Hooper, W. F., Hill, H., Anderson, E. J., Johnson, R., Sanz, P., Pulendran, B., Goll, J. B., and Mulligan, M. J., “Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses.”, Vaccines (Basel), vol. 8, no. 1, 2019.
M. Hudak, Chartrand, S., and Registry, S. Outcomes, “Synagis® (Palivizumab) Prophylaxis of Respiratory Syncytial Virus (RSV) Infection - Patient Dempgraphics and Preliminary Results from 2000-2001 Synagis® Outcomes Registry”, J Perinatology, vol. 21, pp. 500-501, 2001.
I. Hand, Boron, M., and Van Veldhuisen, P., “Synagisâ (Palivizumab) prophylaxis of respiratory syncytial virus (RSV) infection - patient demographics and preliminary results from the 2000-2001 SynagisÒ Outcomes Registry”, 2001.
M. Eydelman, Hilmantel, G., Tarver, M. E., Hofmeister, E. M., May, J., Hammel, K., Hays, R. D., and Ferris, F., “Symptoms and Satisfaction of Patients in the Patient-Reported Outcomes With Laser In Situ Keratomileusis (PROWL) Studies.”, JAMA Ophthalmol, vol. 135, no. 1, pp. 13-22, 2017.
T. McLellan, Tai, B., and Gore-Langton, R., “Symposium: CTN Electronic Medical Records Project - Implication of Adopting Standardized Core-Date Elements in Health IT Systems of Drug Abuse Treatment Providers”, in American Psychological Association (APA) 119th Convention, Washington, DC, 2011.
A. Girach, Aiello, L. P., Milton, R. C., Davis, M. D., Danis, R. P., Zhi, X., Sheetz, M. J., and Vignati, L., “Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy.”, Eye (Lond), vol. 23, no. 1, pp. 209-14, 2009.
A. Girach, Aiello, L., Milton, R., Davis, M., Danis, R., Zhi, X., Sheetz, M., Vignati, L., and Group, P. K. C. - D. R. S. 2Study, “Sustained Moderate Visual Loss as a Predictive End Point for Visual Loss in Non-Proliferative Diabetic Retinopathy”, Eye (Lond), vol. 23, pp. 209-214, 2009.
M. E. Roland, Barin, B., Huprikar, S., Murphy, B., Hanto, D. W., Blumberg, E., Olthoff, K., Simon, D., Hardy, W. D., Beatty, G., and Stock, P. G., “Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls.”, AIDS, vol. 30, no. 3, pp. 435-44, 2016.
D. M. Stablein, Carter, W. H., and Wampler, G. L., “Survival analysis of drug combinations using a hazards model with time-dependent covariates.”, Biometrics, vol. 36, no. 3, pp. 537-46, 1980.
H. O. Douglass, Moertel, C. G., Mayer, R. J., Thomas, P. R., Lindblad, A. S., Mittleman, A., Stablein, D. M., and Bruckner, H. W., “Survival after postoperative combination treatment of rectal cancer.”, N Engl J Med, vol. 315, no. 20, pp. 1294-5, 1986.
A. S. Lindblad, Nolph, K. D., Novak, J. W., and Friedman, E. A., “A survey of the NIH CAPD Registry population with end-stage renal disease attributed to diabetic nephropathy.”, J Diabet Complications, vol. 2, no. 4, pp. 227-32, 1988.
M. G. Greiner, Shulman, M., Opara, O., Potter, K., Voronca, D. C., Tafessu, H. M., Hefner, K., Hamilton, A., Scheele, C., Ho, R., Dresser, L., Jelstrom, E., Fishman, M., Ghitza, U. E., Rotrosen, J., Nunes, E. V., and Bisaga, A., “Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A Stepped Wedge Hybrid Type 1 Effectiveness-Implementation Study”, Contemp Clin Trials, vol. 128, p. 107148, 2023.
J. Harbell, Fung, J., Nissen, N., Olthoff, K., Florman, S. S., Hanto, D. W., Light, J., Bartlett, S. T., Tzakis, A. G., Pearson, T. C., Barin, B., Roland, M. E., and Stock, P. G., “Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients.”, Surgery, vol. 152, no. 3, pp. 376-81, 2012.
J. Harbell, Fung, J., Nissen, N., Olthoff, K., Florman, S., Hanto, D., Light, J., Bartlett, S., Tzakis, A., Pearson, T., Barin, B., Roland, M., and Stock, P., “Surgical Complications in 275 HIV-Infected Liver and/or Kidney Transplantation Recipients”, Surgery, vol. 152, pp. 376-381, 2012.
“Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes.”, Pediatrics, vol. 105, no. 2, pp. 295-310, 2000.
T. S. T. O. P. - R. O. P. M. Group, “Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized controlled trial 1: Primary outcomes”, Pediatrics, vol. 105, pp. 295-310, 2000.
E. Y. Chew, Lindblad, A. S., and Clemons, T., “Summary results and recommendations from the age-related eye disease study.”, Arch Ophthalmol, vol. 127, no. 12, pp. 1678-9, 2009.
E. Chew, Lindblad, A., Clemons, T., and Group, A. - R. Eye Diseas, “Summary Results and Recommendations from the Age-Related Eye Disease Study”, Arch Ophthalmol, vol. 127, pp. 1678-1679, 2009.
S. P. Lerner, Bajorin, D. F., Dinney, C. P., Efstathiou, J. A., Groshen, S., Hahn, N. M., Hansel, D., Kwiatkowski, D., O'Donnell, M., Rosenberg, J., Svatek, R., Abrams, J. S., Al-Ahmadie, H., Apolo, A. B., Bellmunt, J., Callahan, M., Cha, E. K., Drake, C., Jarow, J., Kamat, A., Kim, W., Knowles, M., Mann, B., Marchionni, L., McConkey, D., McShane, L., Ramirez, N., Sharabi, A., Sharpe, A. H., Solit, D., Tangen, C. M., Amiri, A. Tawab, Van Allen, E., West, P. J., Witjes, J. A., and Quale, D. Zipursky, “Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer.”, Bladder Cancer, vol. 2, no. 2, pp. 165-202, 2016.
R. Lindblad, Styers, D., and Wood, D., “A Successful Web Seminar Program for Cell Therapy: An Update from the Production Assistance for Cellular Therapies (PACT) Group”, in AABB Annual Meeting & TXPO, Denver, CO, Denver, CO, 2013, No. 2S., vol. 53, p. Supplement AP40.
R. Lindblad, Quinnan, K., and Wood, D., “A Successful Support Program for Cell Therapy: An Update from the Production Assistance for Cellular Therapies (PACT) Group”, Transfusion, vol. 53, p. Supplement AP34, 2013.